Filing Details
- Accession Number:
- 0001493152-24-040439
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-10-08 16:10:16
- Reporting Period:
- 2024-08-09
- Accepted Time:
- 2024-10-08 16:10:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1861657 | Tharimmune Inc. | THAR | Pharmaceutical Preparations (2834) | 842642541 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1901565 | Sireesh Appajosyula | C/O Tharimmune, Inc. 1200 Route 22 East, Suite 2000 Bridgewater NJ 08807 | Chief Operating Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-10-08 | 5,000 | $1.93 | 16,364 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 38,889 | Indirect | See footnote |
| Common Stock | 304 | Indirect | See footnote |
Footnotes
- 38,889 shares of common stock are held indirectly by Highpoint Pharmaceuticals, LLC and 304 shares of common stock are held by Channel BioConsulting LLC. The Reporting Person is the managing member of each of Highpoint Pharmaceuticals, LLC and Channel BioConsulting LLC and in such capacity has the right to vote and dispose of the securities held by such entities.
Billionaire Hedge Funds
